These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23714528)

  • 1. Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target.
    Juergens RA; Rudin CM
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results.
    Pasini A; Delmonte A; Tesei A; Calistri D; Giordano E
    Drugs; 2015 Oct; 75(15):1757-71. PubMed ID: 26347133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA and histone methylation in gastric carcinogenesis.
    Calcagno DQ; Gigek CO; Chen ES; Burbano RR; Smith Mde A
    World J Gastroenterol; 2013 Feb; 19(8):1182-92. PubMed ID: 23482412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New biomarkers and therapeutics can be discovered during COPD-lung cancer transition.
    Wang X
    Cell Biol Toxicol; 2016 Oct; 32(5):359-61. PubMed ID: 27405768
    [No Abstract]   [Full Text] [Related]  

  • 5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of epigenetics in malignant pleural mesothelioma.
    Vandermeers F; Neelature Sriramareddy S; Costa C; Hubaux R; Cosse JP; Willems L
    Lung Cancer; 2013 Sep; 81(3):311-318. PubMed ID: 23790315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of epigenetic alterations in lung carcinogenesis.
    Brzeziańska E; Dutkowska A; Antczak A
    Mol Biol Rep; 2013 Jan; 40(1):309-25. PubMed ID: 23086271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGI-110 and entinostat therapy reduces lung tumor burden and reprograms the epigenome.
    Tellez CS; Grimes MJ; Picchi MA; Liu Y; March TH; Reed MD; Oganesian A; Taverna P; Belinsky SA
    Int J Cancer; 2014 Nov; 135(9):2223-31. PubMed ID: 24668305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.
    Neureiter D; Jäger T; Ocker M; Kiesslich T
    World J Gastroenterol; 2014 Jun; 20(24):7830-48. PubMed ID: 24976721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.
    Juergens RA; Wrangle J; Vendetti FP; Murphy SC; Zhao M; Coleman B; Sebree R; Rodgers K; Hooker CM; Franco N; Lee B; Tsai S; Delgado IE; Rudek MA; Belinsky SA; Herman JG; Baylin SB; Brock MV; Rudin CM
    Cancer Discov; 2011 Dec; 1(7):598-607. PubMed ID: 22586682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all-trans retinoic acid.
    Greve G; Schiffmann I; Lübbert M
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2171-80. PubMed ID: 26008188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic mechanisms in oral carcinogenesis.
    Gasche JA; Goel A
    Future Oncol; 2012 Nov; 8(11):1407-25. PubMed ID: 23148615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases.
    Vendetti FP; Rudin CM
    Expert Opin Biol Ther; 2013 Sep; 13(9):1273-85. PubMed ID: 23859704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entinostat (SNDX-275) for the treatment of non-small cell lung cancer.
    Ruiz R; Raez LE; Rolfo C
    Expert Opin Investig Drugs; 2015; 24(8):1101-9. PubMed ID: 26098363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer epigenetics: From knowledge to applications.
    Duruisseaux M; Esteller M
    Semin Cancer Biol; 2018 Aug; 51():116-128. PubMed ID: 28919484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic therapy for solid tumors: from bench science to clinical trials.
    Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
    Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenome-Based Precision Medicine in Lung Cancer.
    Kim D; Kim DH
    Methods Mol Biol; 2018; 1856():57-85. PubMed ID: 30178246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anti-cancer strategies: epigenetic therapies and biomarkers.
    Balch C; Montgomery JS; Paik HI; Kim S; Kim S; Huang TH; Nephew KP
    Front Biosci; 2005 May; 10():1897-931. PubMed ID: 15769674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.